Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Physician Education × regorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 9 Carcinoma, Hepatocellular 4 Rectal Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Thrombocytosis 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Physician Education 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 6 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Pancreatic Adenocarcinoma 1 Melanoma 1 MSI-H Colorectal Cancer 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02287025 2017-10-19

SMART

Bayer

Phase 4 Terminated

23 enrolled 6 charts

Physician Education

Data powered by HemOnc (CC BY 4.0) Colophon ⚡